Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2024-04-16

Clinical Trial Update: Study to Assess the Efficacy and Safety of Orismilast in Psoriasis [Phase 2]

View source ↗

Summary

Phase 2 trial assessing the efficacy and safety of orismilast in psoriasis has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Orismilast (orismilast)

Snippet

Sponsor: UNION therapeutics | Conditions: Psoriasis, Skin Diseases | Phase 2 | Status: COMPLETED | Results posted: 2024-04-16